Legacy Wealth Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History
Legacy Wealth Asset Management, LLC
- $331 Million
- Q2 2025
A detailed history of Legacy Wealth Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 1,416 shares of VRTX stock, worth $519,020. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,416
Previous 1,429
0.91%
Holding current value
$519,020
Previous $692,000
8.96%
% of portfolio
0.19%
Previous 0.22%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,816Shares Held
232MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$10.5 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$8.61 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.81 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.33 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.32 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $94.1B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...